After being thrust into the limelight during the Covid-19 pandemic, the medical-pharmaceutical industry continues to witness solid growth, thanks to the high demand for its products irrespective of the economic cycle.
Pharmaceutical companies are known to maintain their profit margins even during economic downturns due to the nature of their businesses. With a recession expected by the end of the year, it could be wise to buy fundamentally strong pharmaceutical stock AbbVie Inc. (ABBV). On the other hand, Catalyst Pharmaceuticals, Inc. (CPRX) could be added to one’s watchlist.
